ARCHIVES

Congress Hasn’t Completed Action Yet On Major Health Bills; Reauthorization Fight In 1988-89

This article is from The Cancer Letter archive.

Vol. 13 No. 29 | July 17, 1987

Download PDF Visit The Full Archive

Related Articles

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

How Elite Institutions Were Affected By A Decade of Constricted Funding

October 31, 2014

Compromise on 6,000 Grants Would Make NCI Payline Around 163-164: Natcher Committee Close to Markup

June 28, 1985

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002